Risk assessment of febrile neutropenia and evaluation of G-CSF use in patients with cancer: a real-life study

Risk of mortality in patients with cancer who experience febrile neutropenia

Gary H. Lyman, Shannon L. Michels, Matthew W. Reynolds et al. · Cancer · 2010 · 247 citations · Full text

Medicine, Oncology, Cancer Epidemiology +13

Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)

Pere Gascón, Matti Aapro, Heinz Ludwig et al. · Supportive Care in Cancer · 2015 · 66 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Prevention of granulocyte-colony stimulating factor (G-CSF) induced bone pain using double histamine blockade

Misty Abrams · Supportive Care in Cancer · 2016 · 39 citations

Nursing, Pharmacotherapy, Pain Management +15

Recommendations for the Use of White Blood Cell Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update

Thomas J. Smith, Kari Bohlke, Jamés O. Armitage · Journal of Oncology Practice · 2015 · 36 citations · Full text

Medicine, Hematology, Oncology +17

Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy—findings from clinical practice

Krzysztof Krzemieniecki, P. Sevelda, Frans Erdkamp et al. · Supportive Care in Cancer · 2013 · 30 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15